CCL2 and nephrolithiasis: For example, metformin prevents kidney stone formation by attenuating oxalic acid-induced lipid peroxidation products-induced tubular damage and by inhibiting the expression of osteopontin (OPN) and monocyte chemoattractant protein 1 (MCP-1) (54, 55).